110 related articles for article (PubMed ID: 10413213)
21. Refractory massive pleural effusion in systemic lupus erythematosus treated by pleurectomy.
Elborn JS; Conn P; Roberts SD
Ann Rheum Dis; 1987 Jan; 46(1):77-80. PubMed ID: 3813678
[TBL] [Abstract][Full Text] [Related]
22. Tocilizumab for massive refractory pleural effusion in an adolescent with systemic lupus erythematosus.
De Matteis A; Sacco E; Celani C; Uva A; Messia V; Nicolai R; Pardeo M; De Benedetti F; Bracaglia C
Pediatr Rheumatol Online J; 2021 Sep; 19(1):144. PubMed ID: 34530845
[TBL] [Abstract][Full Text] [Related]
23. [Febrile state and pleural effusion].
Truninger K; Maurer C; Steurer J
Praxis (Bern 1994); 1996 Sep; 85(36):1091-5. PubMed ID: 8927882
[TBL] [Abstract][Full Text] [Related]
24. ANA positivity and complement level in pleural fluid are potential diagnostic markers in discriminating lupus pleuritis from pleural effusion of other aetiologies.
Chen DY; Huang YH; Chen YM; Chen JJW; Yang TY; Chang GC; Tang KT
Lupus Sci Med; 2021 Nov; 8(1):. PubMed ID: 34785570
[TBL] [Abstract][Full Text] [Related]
25. Pleural fluid soluble interleukin 2 receptor in rheumatoid arthritis and systemic lupus erythematosus.
Pettersson T; Söderblom T; Nyberg P; Riska H; Linko L; Klockars M
J Rheumatol; 1994 Oct; 21(10):1820-4. PubMed ID: 7837144
[TBL] [Abstract][Full Text] [Related]
26. Antinuclear antibody positive pleural effusion in a patient with tuberculosis.
Win T; Groves AM; Phillips GD
Respirology; 2003 Sep; 8(3):396-7. PubMed ID: 14528888
[TBL] [Abstract][Full Text] [Related]
27. Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases.
Hunder GG; McDuffie FC; Huston KA; Elveback LR; Hepper NG
J Lab Clin Med; 1977 Dec; 90(6):971-80. PubMed ID: 597373
[TBL] [Abstract][Full Text] [Related]
28. Intravenous immunoglobulin therapy in a patient with lupus serositis and nephritis.
Meissner M; Sherer Y; Levy Y; Chwalinska-Sadowska H; Langevitz P; Shoenfeld Y
Rheumatol Int; 2000; 19(5):199-201. PubMed ID: 10984139
[TBL] [Abstract][Full Text] [Related]
29. [Relationship of renal histopathology to immunoglobulin classes and complement fixation of anti-native DNA antibodies and components of immune complexes in patients with systemic lupus erythematosus (author's transl)].
Hashimoto H; Utagawa Y; Yamagata J; Okada T; Shiokawa Y; Suzuki S; Tomiyama T
Ryumachi; 1981 Sep; 21(5):366-74. PubMed ID: 6977194
[No Abstract] [Full Text] [Related]
30. Diffuse edema and bilateral massive pleural effusion as the presentation of systemic lupus erythematosus.
Aslan M; Bicak U; Dogan DG; Dogan M; Yakinci C
Lupus; 2011 Mar; 20(3):308-10. PubMed ID: 20921153
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic options for refractory massive pleural effusion in systemic lupus erythematosus: a case study and review of the literature.
Breuer GS; Deeb M; Fisher D; Nesher G
Semin Arthritis Rheum; 2005 Apr; 34(5):744-9. PubMed ID: 15846590
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of systemic lupus erythematosus by presence of Hargraves cells in eosinophilic pleural effusion: Case report.
D'Andréa A; L Peillet D; Serratrice C; Petignat PA; Prendki V; Reny JL; Serratrice J
Medicine (Baltimore); 2018 Oct; 97(42):e12871. PubMed ID: 30335001
[TBL] [Abstract][Full Text] [Related]
33. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis.
Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA
Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852
[TBL] [Abstract][Full Text] [Related]
34. Pleural effusion in systemic lupus erythematosus.
Reda MG; Baigelman W
Acta Cytol; 1980; 24(6):553-7. PubMed ID: 6160709
[TBL] [Abstract][Full Text] [Related]
35. Pleuritis and pleural effusion as the initial presentation of systemic lupus erythematous in a 23-year-old woman.
Wan KS
Rheumatol Int; 2008 Oct; 28(12):1257-60. PubMed ID: 18496695
[TBL] [Abstract][Full Text] [Related]
36. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients.
Saisoong S; Eiam-Ong S; Hanvivatvong O
Clin Exp Rheumatol; 2006; 24(1):51-8. PubMed ID: 16539819
[TBL] [Abstract][Full Text] [Related]
37. Steroid resistant pleural effusion in systemic lupus erythematosus treated with tetracycline pleurodesis.
Gilleece MH; Evans CC; Bucknall RC
Ann Rheum Dis; 1988 Dec; 47(12):1031-2. PubMed ID: 3207386
[TBL] [Abstract][Full Text] [Related]
38. Post-traumatic pleural effusion: demonstration of local complement consumption.
de Blay F; Aykut-Baturalp A; Goetz J; Purohit A; Perez-Infante A; Hauptmann G; Pauli G
Respir Med; 1997 Jul; 91(6):373-5. PubMed ID: 9282241
[TBL] [Abstract][Full Text] [Related]
39. Etiologies and outcomes of pleural effusions in patients with systemic lupus erythematosus.
Palavutitotai N; Buppajarntham T; Katchamart W
J Clin Rheumatol; 2014 Dec; 20(8):418-21. PubMed ID: 25417677
[TBL] [Abstract][Full Text] [Related]
40. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
